Evidence map›Paper›PMID 33183249›Full record

ArticleBMC psychiatry2020

Prevalence of symptoms, ever having received a diagnosis and treatment of depression and anxiety, and associations with health service use amongst the general population in two Russian cities.

Sarah Cook, Alexander V Kudryavtsev, Natalia Bobrova, Lyudmila Saburova, Diana Denisova, Sofia Malyutina, Glyn Lewis, David A Leon

Abstract read
In one paragraph

Article in BMC psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sarah CookDepartment of Community Medicine, UiT the Arctic University of Norway, Tromsø, Norway. sarah.cook@uit.no.ORCID 0000-0003-1250-2967
Alexander V KudryavtsevDepartment of Community Medicine, UiT the Arctic University of Norway, Tromsø, Norway.
Natalia BobrovaFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
Lyudmila SaburovaInstitute of Philosophy and Law, Ural Branch of the Russian Academy of Sciences, Ekaterinburg, Russian Federation.
Diana DenisovaResearch Institute of Internal and Preventive Medicine, Branch of Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russian Federation.
Sofia MalyutinaResearch Institute of Internal and Preventive Medicine, Branch of Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russian Federation.
Glyn LewisDivision of Psychiatry, University College London, London, UK.
David A LeonDepartment of Community Medicine, UiT the Arctic University of Norway, Tromsø, Norway.

Funding

Norwegian Institute of Public Health N/ANorwegian Ministry of Health and Social Affairs N/AUiT The Arctic University of Norway N/AWellcome TrustWellcome Trust 100217
6 · The paper itself

Abstract

backgroundLittle is known about the burden of common mental disorders in Russia despite high levels of suicide and alcohol-related mortality. Here we investigated levels of symptoms, self-reports of ever having received a diagnosis and treatment of anxiety and depression in two Russian cities.

methodsThe study population was men and women aged 35-69 years old participating in cross-sectional population-based studies in the cities of Arkhangelsk and Novosibirsk (2015-18). Participants completed an interview which included the PHQ-9 and GAD-7 scales, questions on whether participants had ever received a diagnosis of depression or anxiety, and health service use in the past year. Participants also reported current medication use and medications were coded in line with the WHO anatomical therapeutic classification (ATC). Depression was defined as PHQ-9 ≥ 10 and Anxiety as GAD-7 ≥ 10.

resultsAge-standardised prevalence of PHQ-9 ≥ 10 was 10.7% in women and 5.4% in men (GAD-7 ≥ 10 6.2% in women; 3.0% in men). Among those with PHQ-9 ≥ 10 17% reported ever having been diagnosed with depression (equivalent finding for anxiety 29%). Only 1.5% of those with PHQ-9 ≥ 10 reported using anti-depressants and 0.6% of those with GAD-7 ≥ 10 reported using anxiolytics. No men with PHQ-9 ≥ 10 and/or GAD-7 ≥ 10 reported use of anti-depressants or anxiolytics. Use of health services increased with increasing severity of both depression and anxiety.

conclusionThere was a large gap between symptoms and reporting of past diagnosis and treatment of common mental disorders in two Russian cities. Interventions aimed at improving mental health literacy and reducing stigma could be of benefit in closing this substantial treatment gap.

Indexed as

AnxietyDepressionAdultAgedCitiesCross-Sectional StudiesFemaleHealth ServicesHumansMaleMiddle AgedPrevalenceRussiaAnti-depressantsAnxietyAnxiolyticsDepressionMental disordersRussian FederationTreatment of mental disorders

Identifiers

PMID33183249
PMCPMC7663865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.